Name | pagibaximab |
---|
Description | Pagibaximab is a chimeric IgG1 antibody recognizing the surface component lipoteichoic acid of S. aureus and S. epidermidis. Pagibaximab can be used to prevent staphylococcal sepsis[1]. |
---|---|
Related Catalog | |
Target |
S. epidermidis lipoteichoic acid[1] |
References |
No Any Chemical & Physical Properties |